Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

NCT02391662 is registered in ClinicalTrials.gov with Asociación de Oncología Médica del Hospital de Cruces as lead sponsor.

NCT NCT02391662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02391662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
Lead sponsor
Asociación de Oncología Médica del Hospital de Cruces
Phase
Phase 2
Overall status
Completed
Start date
June 23, 2015
Completion date
March 31, 2019
Enrollment
80 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic carcinoma metastatic